Epstein Secrets

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

ural areas of states at the expense of more diverse cities." The New York Post (7/21, Bowden, 4.57M), Axios (7/21, Allassan, 521K), Bloomberg (7/21, Korte, 4.73M), The Hill (7/21, Samuels, Bernal, 2.98M) and Sreitharf (7/21, Binder, 673K), among other news outlets, also cover the story. White House C

s-may- ready-early-2021/5478232002/> (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Modema and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory guid

Bloomberg <https://www.bloomberg.corn/news/articles/2020-07-21/trump-order-on-census-immigrants-shifts-power-from- three-states?smd=premium> (7/21, Korte, 4.73M), The Hill <https://thehill.com/latino/508314-trump-aims-to- bar-undocumented-immigrants-from-counting-toward-house-representation> (7/21, Sam

. The New York Post <https://nypost.corn/2020/07/30/johnson-johnson-starts-human-vaccine-trials-after-monkey- study/> (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmaker

Bloomberg <https://www.bloomberg.corn/news/articles/2020-07-30/changing-the-election-date- would-be-difficult-even-for-congress?srnd=premium> (7/30, Korte, 4.73M), McClatchy <https://www.mcclatchydc.com/news/nation-world/national/article244595962.html#cardLink=row2_cardl> (7/30, Jasper, 19K), the Wash

ication, 8.41M) also have reports. J&J Says It Should Have Enough Doses For More Than 20M By End Of March. The Hill (2/22, Sullivan, 5.69M) reports Johnson & Johnson said Monday that it "plans to have enough doses of its vaccine for more than 20 million Americans by the end of March" if its vaccine is authorized

te their ideas and concerns, but to make them a permanent part of the policy making process." Biden Raised $22.1M For Transition. Bloomberg (2/22, Korte, 3.57M) reports data released Monday by the GSA show that President Biden "raised $22.1 million to pay for the costs of his transition, far exceedin

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

Daily Caller (7/30, Datoc, 716K) headlines its report "'No Way' - Top Republicans Kill Trump's Hopes For A Delayed 2020 Election." Bloomberg (7/30, Korte, 4.73M), McClatchy (7/30, Jasper, 19K), the Washington Times (7/30, Boyer, 492K), and CQ Roll Call (7/30, Ruger, 154K) are among the other sources

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

ral areas of states at the expense of more diverse cities." The New York Post (7/21, Bowden, 4.57M), Axios (7/21, Allassan, 521K), Bloomberg (7/21, Korte, 4.73M), The Hill (7/21, Samuels, Bernal, 2.98M) and Breitbart (7/21, Binder, 673K), among other news outlets, also cover the story. White House Co

ompromise Vaccine Safety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory gu

ral areas of states at the expense of more diverse cities." The New York Post (7/21, Bowden, 4.57M), Axios (7/21, Allassan, 521K), Bloomberg (7/21, Korte, 4.73M), The Hill (7/21, Samuels, Bernal, 2.98M) and Breitbart (7/21, Binder, 673K), among other news outlets, also cover the story. White House Co

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

Daily Caller (7/30, Datoc, 716K) headlines its report "'No Way' - Top Republicans Kill Trump's Hopes For A Delayed 2020 Election." Bloomberg (7/30, Korte, 4.73M), McClatchy (7/30, Jasper, 19K), the Washington Times (7/30, Boyer, 492K), and CQ Roll Call (7/30, Ruger, 154K) are among the other sources